Hester Biosciences (BOM:524669) ROCE % : 0.57% (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Hester Biosciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hester Biosciences's annualized ROCE % for the quarter that ended in Dec. 2024 was 0.57%.

Hester Biosciences ROCE % Historical Data

The historical data trend for Hester Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hester Biosciences ROCE % Chart

Hester Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

17.23

17.21

13.76

9.18

7.62

Hester Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															6.24	4.42	11.21	13.09	0.57

Hester Biosciences ROCE % Calculation

Hester Biosciences's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	410.72	/	( ( (6699.66 - 1486.96)	+	(6623.47 - 1057.85) )	/ 2 )
	=	410.72	/	( (5212.7	+	5565.62)	/ 2 )
	=	410.72	/	5389.16
	=	7.62 %

Hester Biosciences's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	30.8	/	( ( (6692.5 - 1268.13)	+	(0 - 0) )	/ 1 )
	=	30.8	/	( ( 5424.37	+	0 )	/ 1 )
	=	30.8	/	5424.37
	=	0.57 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Hester Biosciences (BOM:524669) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hester Biosciences ROCE % Related Terms

Thank you for viewing the detailed overview of Hester Biosciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hester Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » ROCE %

Traded in Other Exchanges

HESTERBIO:India

Address

Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006

Website

https://www.hester.in

Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines